HCS, HCA & Biology
Deep Learning: An AI-Driven Genomics Company Is Turning to Drugs
A new era of information-based medicine
english
Precision Medicine, the good way to cure complexe diseases
Precision medicine is a new step in healthcare
english
Poster presentation during the “advances in cell engineering, imaging and screening conference”
Méryl Roudaut* will present a poster on the work of Institut du Thorax
english
Poster – Neurotoxicity assay using High Content Screening technology
As shown by AstraZeneca in nature reviews, one third of the safety failures is linked to CNS toxicity during the clinical trials of drugs .
english
Poster – Development of an Automated Comet Assay for Genotoxicity Assessment on TK6 cell line
Quantifying DNA damage is mandatory to assess potential adverse effects of candidate drugs or molecules or extracts developed in the dermo-cosmetic industry, but also to assess the efficacy of therapeutic approaches with the aim of producing tumor cell genotoxicity in cancer treatment.
english
Open innovation to sharing the risk
The pharmaceutical industry is in upheaval. Since 20 years, inefficiency of pharmaceutical industry to turn its discoveries into new drugs force them to change their model.
english
organ-on-a-chip / body-on-a-chip, a way for personalized medecine?
Since few years, the technology is more and more used to finaly create organ-on-a-chip and now body-on-chip with different organs.
english
Feedback of biofit 2015 in Strasbourg
As last year, we were present in Biofit. This congress is one of the best european place to be for B2B meetings. I had around 20 B to B meetings.
english
White paper about phenotypic screening in drugs discovery
« Phenotypic Drug Discovery with High Content Screening » by Permin Elmer
english
Meet us at Drug Discovery 2015 in Telford the 2nd & 3rd of September
We will be present in the “innovation zone” during the Drug discovery 2015 in Telford the 2nd and 3rd of September in Telford.
english
Automation of imaging for in vivo studies
NIH Grant has been awarded to Hudson Robotics and Johns Hopkins University for in vivo Studies. Cell imaging on in vivo studies on whole organism as zebrafish is a powerfull tool during drug discovery. Nevertheless, the throughput is really low to be used during preliminary drug discovery. Working on implementation Read more…
english
My impression of ELRIG Drug Discovery 2014
I was really impressed by the size and quality of the Drug Discovery 2014 organised by ELRIG in Manchester. More than 1,500 scientists participated in this meeting and nearly 100 exhibitors were present. Phentoypic screening and high content screening were prominent in this conference and we could hear researchers from Roche, Astrazeneca, Read more…